This primary objective of this study is to describe the incidence of RSV infection in adult hematopoietic cell transplant recipients OR hematological malignancies patients in Tianjin HI.
Study Type
OBSERVATIONAL
Enrollment
500
No intervention; Epidemiological Study. Participants will receive standard care based on local clinical practice
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
Tianjin, China
RECRUITINGthe incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the study site
infection incidence
Time frame: 1 year
the Incidence of RSV infection in adult hematopoietic stem cell transplantation (HCT) recipients OR hematological malignancies (HM) patients presenting the hospital
infection incidence
Time frame: 1 year
the clinical characteristics of RSV infection
symptoms description and scoring of RSV infection
Time frame: 1 year
Clinical outcome and relevant risk factor of RSV infection
Clinical outcome and relevant risk factor of RSV infection
Time frame: 1 year
Virological characteristics of RSV infection from D1 through D28, D42 or even longer
Clinical outcome and relevant risk factor of RSV infection
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.